Qing Li

LBA2 Sintilimab plus bevacizumab biosimilar vs sorafenib as first-line treatment for advanced hepatocellular carcinoma (ORIENT-32)2

Minhu Chen, Zhengming Chen, G. Shao, 2020 .

A Real-World Study of Optimal Treatment with Anlotinib First-Line Therapy in Advanced Hepatocellular Carcinoma

Xu Zhang, Xiaojuan Gao, Tong Su, 2022, Cancer management and research.

CMAR_A_379911 3037..3046

Xu Zhang, Xiaojuan Gao, Tong Su, 2022 .

A phase Ib study of TAK-079, an investigational anti-CD38 monoclonal antibody (mAb) in patients with relapsed/ refractory multiple myeloma (RRMM): Preliminary results.

S. Jagannath, A. Krishnan, P. Hari, 2020 .